Navigation Links
Cobalis Corp. Appoints Martin Marion as Chief Executive Officer
Date:5/13/2010

profitability. His extensive healthcare agency and consulting background combined with his first-hand knowledge of PreHistin® enable him to hit the ground running, and immediately commence our marketing launch strategies. We are pleased to welcome Marty back to the Cobalis family as our CEO.”

Marion added: “Cobalis holds tremendous potential, not only for PreHistin® as an entirely new approach to controlling allergies before symptoms arise, but as an innovator and marketer of preventive healthcare products. Our priority now is to quickly build a fundamental and profitable company, engage a team of best-in-class partners to execute our strategies, and thus increase shareholder value. We understand the challenges that lie ahead and our team is prepared to make the smart decisions necessary to successfully bring PreHistin® to market in the US and internationally.”

ABOUT COBALIS CORP—PREHISTIN®
Cobalis Corp. is a specialty pharmaceutical, nutraceutical and preventive healthcare product development and marketing company. Its flagship product, PreHistin®, The World’s FIRST Pre-Histamine”™, is designed to mitigate overproduction of IgE levels and restore a normal response to seasonal and year-round indoor and outdoor allergens. PreHistin® is available without prescription for both long-term and daily use.
For PreHistin® product information and ordering please visit at www.PreHistin.com or call toll free
1-877-4POLLEN. For additional company information please visit the corporate website at www.Cobalis.com.

CONTACT
Cobalis Corp.
2030 Main St., Suite 1300
Irvine, CA 92614
949-260-9007
Chas Radovich, President
Martin Marion, CEO
info (at)
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
3. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
4. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
5. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
6. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
7. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
8. Helix BioPharma Corp. announces fiscal 2007 results
9. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
10. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
11. Helix BioPharma Corp. announces management changes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cobalis Corp. Appoints Martin Marion as Chief Executive Officer  
(Date:7/24/2014)... Yushan Yan, Distinguished Professor of Engineering at the ... nanomaterials to solve problems in energy engineering, environmental ... focused on zeolites, porous rock with a well-defined, ... size is so precisely decided that zeolites can ... fraction of an angstrom (one-tenth of a nanometer), ...
(Date:7/24/2014)... 24, 2014 Your cell phone ... modeling lithium-ion battery storage capacity. , New research ... theoretical model created at Lawrence Livermore National ... predicts how carbon components will perform as electrodes. ... the urgent need for higher-performance batteries. Several key ...
(Date:7/24/2014)... 2014 2014 Deep Research Report ... a professional and in-depth research report on Potassium ... basic information, including its definition, classification, application, ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis, the ...
(Date:7/24/2014)... The first part of the session on ... Human Studies” will cover comprehensive clinical support in early ... increasing R&D costs and declining industry success in getting ... knowledge collected in early Phase I/IIa study data to ... stage development. , Next, the presenters will examine steps ...
Breaking Biology Technology:University of Delaware researcher describes new approach for creating organic zeolites 2Getting More Life out of Lithium-ion Batteries 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
... (Nasdaq and MTA: CTIC) announced today that it received ... with the sale of its 50% interest in the ... that closed in March 2009. CTI previously received approximately ... transaction, and the remaining $3.5 million, subject to adjustments ...
... 3 Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) ... company,s three hepatitis C programs at the Canaccord Adams Hepatitis ... at the InterContinental The Barclay New York Hotel in New ... be accessed under "Calendar of Events" in the Idenix Investor ...
... IRVINE, Calif., April 3 ChromaDex Corporation, (OTC ... standards and contract research, today announced financial results ... basis calculated in accordance with U.S. Generally Accepted ... loss attributable to common stockholders of $0.07 per ...
Cached Biology Technology:CTI Receives the Second Payment of $6.5 million Associated with the Sale of Interest in Zevalin Joint Venture 2CTI Receives the Second Payment of $6.5 million Associated with the Sale of Interest in Zevalin Joint Venture 3ChromaDex Announces 2008 Year End Financial Results 2ChromaDex Announces 2008 Year End Financial Results 3
(Date:7/25/2014)... and disrupted brain development is an essential part ... largely unknown. However, thanks to funding from the ... University (GW) researcher Anthony-Samuel LaMantia, Ph.D. may be ... to these key questions in the field of ... and physiology at the GW School of Medicine ...
(Date:7/25/2014)... at the University of Houston, has written a ... development., "Introduction to Tissue Engineering: Applications and Challenges" ... field of artificial organ development. Metin Akay, founding ... served as a series editor on the book., ... books on the subject of growing artificial organs ...
(Date:7/25/2014)... factor characterized by the existence of numerous isoforms ... to the protein deeply different characteristics. NRG1 plays ... during development and the different phases occurring after ... regrowth, remyelination and target reinnervation, Researchers at the ... soluble NRG1 upregulation observed in Schwann cells immediately ...
Breaking Biology News(10 mins):GW researcher receives grant to answer the how and why of autism during development 2University of Houston researcher publishes textbook on tissue engineering 2
... working on behalf of the European Pet Food Industry ... vitamin A consumption for puppies. The research marks a ... for vitamin A levels for puppies and sheds new ... research was conducted by scientists from the Free University ...
... molecules in our bodies display a striking molecular characteristic: They ... of each other, like your right hand and left hand. ... molecular forms. This mirror-image phenomenon known ... a UCLA research group led by Thomas G. Mason, a ...
... designer from Africa have together created a fashionable hooded ... warding off mosquitoes infected with malaria, a disease estimated ... Though insecticide-treated nets are commonly used to drive away ... be worn throughout the day to provide extra protection ...
Cached Biology News:Collaborative research team identifies safe upper level for vitamin A consumption for puppies 2UCLA life scientists unlock mystery of how 'handedness' arises 2UCLA life scientists unlock mystery of how 'handedness' arises 3African scientist, designer partner to fashion anti-malaria garment that wards off bugs 2
...
Applications: Western blotting ...
...
Ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid...
Biology Products: